9,10-dimethyl-1,2-benzanthracene has been researched along with fenretinide in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (69.23) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abou-Issa, H; Koolemans-Beynen, A; Meredith, TA; Webb, TE | 1 |
Abou-Issa, H; Minton, JP; Moeschberger, M; Webb, TE | 1 |
Banerjee, MR; Manoharan, K | 1 |
Bagg, BJ; Hultin, TA; McCormick, DL | 1 |
Bollag, W; Hartmann, HR | 1 |
Abou-Issa, HM; Duruibe, VA; Dwivedi, C; Larroya, S; Minton, JP; Webb, TE | 1 |
Banerjee, MR; Chatterjee, M | 1 |
Katayama, S; Levenstein, MJ; Radok, P; Silverman, J; Weisburger, JH | 1 |
DeHoog, JV; Moon, RC; Welsch, CW | 1 |
Caldwell, JA; Dinger, N; McCormick, DL; Mehta, RG; Moon, RC; Thompson, CA | 1 |
Abou-Issa, H; Ahrens, J; Alshafie, G; Clagett-Dame, M; Curley, RW; Nieves, N; Walker, JR | 1 |
Capodiferro, S; Favia, G; Giuliani, M; Lajolo, C; Lucchese, A; Majorano, E; Sgambato, A | 1 |
Alakavuklar, M; Canda, T; Cehreli, R; Guner, G; Gurel, D; Kocdor, H; Kocdor, MA; Yilmaz, O | 1 |
13 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and fenretinide
Article | Year |
---|---|
Antitumour synergism between non-toxic dietary combinations of isotretinoin and glucarate.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Female; Fenretinide; Glucaric Acid; Isotretinoin; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Tretinoin | 1992 |
Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Female; Fenretinide; Glucaric Acid; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Tretinoin | 1989 |
beta-Carotene reduces sister chromatid exchanges induced by chemical carcinogens in mouse mammary cells in organ culture.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; beta Carotene; Carcinogens; Carotenoids; Cell Transformation, Neoplastic; Diethylnitrosamine; Female; Fenretinide; Mammary Glands, Animal; Methylnitrosourea; Mice; Organ Culture Techniques; Retinoids; Sister Chromatid Exchange; Tretinoin | 1985 |
Comparative activity of dietary or topical exposure to three retinoids in the promotion of skin tumor induction in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Carcinogens; Diet; Female; Fenretinide; Isomerism; Mice; Mice, Inbred Strains; Skin Neoplasms; Structure-Activity Relationship; Tretinoin | 1987 |
Inhibition of rat mammary carcinogenesis by an arotinoid without a polar end group (Ro 15-0778).
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Dose-Response Relationship, Drug; Female; Fenretinide; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Retinoids; Time Factors; Tretinoin | 1987 |
Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Diet; Drug Synergism; Fenretinide; Glucaric Acid; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Sugar Acids; Tretinoin | 1988 |
Influence of hormones on N-(4-hydroxyphenyl) retinamide inhibition of 7,12-dimethylbenz[alpha]anthracene transformation of mammary cells in organ culture.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Castration; Cell Transformation, Neoplastic; Estrogens; Female; Fenretinide; Hormones; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Organ Culture Techniques; Progesterone; Tretinoin | 1982 |
Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Tretinoin | 1983 |
Lack of an effect of dietary retinoids in chemical carcinogenesis of the mouse mammary gland: inverse relationship between mammary tumor cell anaplasia and retinoid efficacy.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Anaplasia; Animals; Diet; Diterpenes; Female; Fenretinide; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Retinoids; Retinyl Esters; Species Specificity; Tretinoin; Vitamin A | 1984 |
Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Castration; Diet; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Time Factors; Tretinoin | 1982 |
Synthesis and preliminary chemotherapeutic evaluation of the fully C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Female; Fenretinide; Glucuronides; Molecular Structure; Rats; Rats, Sprague-Dawley | 2006 |
N-(4-hydroxyphenyl)all-trans-retinamide (4-HPR) high dose effect on DMBA-induced hamster oral cancer: a histomorphometric evaluation.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Anticarcinogenic Agents; Atrophy; Carcinogens; Carcinoma; Carcinoma in Situ; Cell Nucleus; Chemoprevention; Connective Tissue; Cricetinae; Epithelium; Fenretinide; Hyperplasia; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Neoplasm Invasiveness; Time Factors | 2008 |
Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carcinogens; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Fenretinide; Hypoglycemic Agents; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Prolactin; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2009 |